298 related articles for article (PubMed ID: 22691433)
1. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
[TBL] [Abstract][Full Text] [Related]
2. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
6. Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.
Pincha M; Sundarasetty BS; Salguero G; Gutzmer R; Garritsen H; Macke L; Schneider A; Lenz D; Figueiredo C; Blasczyk R; Ruggiero E; Schmidt M; von Kalle C; Puff C; Modlich U; von der Leyen H; Wicke DC; Ganser A; Stripecke R
Hum Gene Ther Methods; 2012 Feb; 23(1):38-55. PubMed ID: 22428979
[TBL] [Abstract][Full Text] [Related]
7. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
Forsberg O; Carlsson B; Tötterman TH; Essand M
Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
[TBL] [Abstract][Full Text] [Related]
8. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
9. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
10. [CMV pp65 gene modified dendritic cells activate autologous T cells].
Gao GX; Chen XQ; Zhang JY; Zhu HF; Dong BX; Gu HT; Gao Y; Pan YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):397-400. PubMed ID: 18426673
[TBL] [Abstract][Full Text] [Related]
11. Immunity of lentiviral vector-modified dendritic cells.
Han S; Chang LJ
Methods Mol Biol; 2009; 542():245-59. PubMed ID: 19565906
[TBL] [Abstract][Full Text] [Related]
12. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
13. Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro.
Koya RC; Weber JS; Kasahara N; Lau R; Villacres MC; Levine AM; Stripecke R
Hum Gene Ther; 2004 Aug; 15(8):733-48. PubMed ID: 15319031
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
[TBL] [Abstract][Full Text] [Related]
15. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.
Sundarasetty BS; Singh VK; Salguero G; Geffers R; Rickmann M; Macke L; Borchers S; Figueiredo C; Schambach A; Gullberg U; Provasi E; Bonini C; Ganser A; Woelfel T; Stripecke R
Hum Gene Ther; 2013 Feb; 24(2):220-37. PubMed ID: 23311414
[TBL] [Abstract][Full Text] [Related]
18. Progress made towards the development of a CMV peptide vaccine.
Paston SJ; Dodi IA; Madrigal JA
Hum Immunol; 2004 May; 65(5):544-9. PubMed ID: 15172455
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation.
Salguero G; Daenthanasanmak A; Münz C; Raykova A; Guzmán CA; Riese P; Figueiredo C; Länger F; Schneider A; Macke L; Sundarasetty BS; Witte T; Ganser A; Stripecke R
J Immunol; 2014 May; 192(10):4636-47. PubMed ID: 24740501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
